354 related articles for article (PubMed ID: 24035275)
1. Paraneoplastic cerebellar degeneration with anti-Yo antibodies associated with metastatic uveal melanoma.
Valpione S; Zoccarato M; Parrozzani R; Pigozzo J; Giometto B; Laveder F; Aliberti C; Chiarion-Sileni V
J Neurol Sci; 2013 Dec; 335(1-2):210-2. PubMed ID: 24035275
[TBL] [Abstract][Full Text] [Related]
2. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a female patient with pleural malignant mesothelioma.
Tanriverdi O; Meydan N; Barutca S; Ozsan N; Gurel D; Veral A
Jpn J Clin Oncol; 2013 May; 43(5):563-8. PubMed ID: 23475537
[TBL] [Abstract][Full Text] [Related]
3. Paraneoplastic cerebellar degeneration caused by ovarian clear-cell carcinoma.
Negishi Y; Sakai K; Noguchi Y; Iwasaki N; Kawai N
J Obstet Gynaecol Res; 2014 Feb; 40(2):614-7. PubMed ID: 24148073
[TBL] [Abstract][Full Text] [Related]
4. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with adenocarcinoma of the gastroesophageal junction.
Debes JD; Lagarde SM; Hulsenboom E; Sillevis Smitt PA; ten Kate FJ; Sulter GA; van Lanschot JJ
Dig Surg; 2007; 24(5):395-7. PubMed ID: 17785986
[TBL] [Abstract][Full Text] [Related]
5. Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: case report and review of the literature.
Cao Y; Abbas J; Wu X; Dooley J; van Amburg AL
Gynecol Oncol; 1999 Oct; 75(1):178-83. PubMed ID: 10502450
[TBL] [Abstract][Full Text] [Related]
6. Deterioration of anti-Yo-associated paraneoplastic cerebellar degeneration.
Finsterer J; Voigtländer T; Grisold W
J Neurol Sci; 2011 Sep; 308(1-2):139-41. PubMed ID: 21762925
[TBL] [Abstract][Full Text] [Related]
7. Seronegative paraneoplastic cerebellar degeneration: the PNS Euronetwork experience.
Ducray F; Demarquay G; Graus F; Decullier E; Antoine JC; Giometto B; Psimaras D; Delattre JY; Carpentier AF; Honnorat J
Eur J Neurol; 2014 May; 21(5):731-5. PubMed ID: 24471811
[TBL] [Abstract][Full Text] [Related]
8. A cerebellar degeneration-related protein 2-like cell-based assay for anti-Yo detection in patients with paraneoplastic cerebellar degeneration.
Erikstad KI; Herdlevaer I; Peter E; Haugen M; Totland C; Vedeler C
Eur J Neurol; 2023 Jun; 30(6):1727-1733. PubMed ID: 36912432
[TBL] [Abstract][Full Text] [Related]
9. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration associated with cognitive affective syndrome in a patient with breast cancer: a case report and literature review.
Le May M; Dent S
Curr Oncol; 2018 Dec; 25(6):e585-e591. PubMed ID: 30607127
[TBL] [Abstract][Full Text] [Related]
10. [Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration].
Basić-Jukić N; Kes P; Basić-Kes V; Brunetta B
Acta Med Croatica; 2004; 58(1):63-6. PubMed ID: 15125396
[TBL] [Abstract][Full Text] [Related]
11. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a man with esophageal adenocarcinoma.
Xia K; Saltzman JR; Carr-Locke DL
MedGenMed; 2003 Aug; 5(3):18. PubMed ID: 14600654
[TBL] [Abstract][Full Text] [Related]
12. Human epidermal growth factor receptor 2 overexpression in breast cancer of patients with anti-Yo--associated paraneoplastic cerebellar degeneration.
Rojas-Marcos I; Picard G; Chinchón D; Gelpi E; Psimaras D; Giometto B; Delattre JY; Honnorat J; Graus F
Neuro Oncol; 2012 Apr; 14(4):506-10. PubMed ID: 22351748
[TBL] [Abstract][Full Text] [Related]
13. [Paraneoplastic cerebellar degeneration as initial presentation of a pancreatic small-cell carcinoma].
Salmerón-Ato P; Medrano V; Morales-Ortiz A; Martínez-García FA; Villaverde-González R; Bas A; Fernández-Barreiro A; Moltó-Jordà JM
Rev Neurol; 2002 Dec 16-31; 35(12):1112-5. PubMed ID: 12497294
[TBL] [Abstract][Full Text] [Related]
14. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma.
Meglic B; Graus F; Grad A
J Neurol Sci; 2001 Apr; 185(2):135-8. PubMed ID: 11311295
[TBL] [Abstract][Full Text] [Related]
15. CDR2L Antibodies: A New Player in Paraneoplastic Cerebellar Degeneration.
Eichler TW; Totland C; Haugen M; Qvale TH; Mazengia K; Storstein A; Haukanes BI; Vedeler CA
PLoS One; 2013; 8(6):e66002. PubMed ID: 23823982
[TBL] [Abstract][Full Text] [Related]
16. Cerebellar degeneration-related proteins 2 and 2-like are present in ovarian cancer in patients with and without Yo antibodies.
Raspotnig M; Haugen M; Thorsteinsdottir M; Stefansson I; Salvesen HB; Storstein A; Vedeler CA
Cancer Immunol Immunother; 2017 Nov; 66(11):1463-1471. PubMed ID: 28710511
[TBL] [Abstract][Full Text] [Related]
17. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.
Shams'ili S; Grefkens J; de Leeuw B; van den Bent M; Hooijkaas H; van der Holt B; Vecht C; Sillevis Smitt P
Brain; 2003 Jun; 126(Pt 6):1409-18. PubMed ID: 12764061
[TBL] [Abstract][Full Text] [Related]
18. Transcriptomic immune profiling of ovarian cancers in paraneoplastic cerebellar degeneration associated with anti-Yo antibodies.
Vialatte de Pémille C; Berzero G; Small M; Psimaras D; Giry M; Daniau M; Sanson M; Delattre JY; Honnorat J; Desestret V; Alentorn A
Br J Cancer; 2018 Jul; 119(1):105-113. PubMed ID: 29899393
[TBL] [Abstract][Full Text] [Related]
19. Slow evolution of cerebellar degeneration and chorea in a man with anti-Yo antibodies.
Krolak-Salmon P; Androdias G; Meyronet D; Aguera M; Honnorat J; Vighetto A
Eur J Neurol; 2006 Mar; 13(3):307-8. PubMed ID: 16618353
[No Abstract] [Full Text] [Related]
20. [Paraneoplastic cerebellar degeneration].
Sakai K
Brain Nerve; 2010 Apr; 62(4):357-64. PubMed ID: 20420175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
